Dr. Jeffrey M. Turner, MD

Dr. Turner practices at Yale Medicine in New Haven, Connecticut.

Dr. Turner's NPI, 1881915601, was assigned on June 16, 2010. Dr. Turner graduated from New York Medical College in 2005. Dr. Turner holds Connecticut license 049599.

Dr. Turner's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Turner's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Turner is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Turner to 3 more hospitals and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Turner practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Turner's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Turner is licensed in Connecticut.

CMS data shows 376 Medicare services from Dr. Turner across 5 procedure codes in 2024, for 186 Medicare patients. Medicare paid $23,912 for them.

CMS counts 186 Medicare patients who saw Dr. Turner in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 46% are also on Medicaid. Their average risk score is 4.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Turner's median patient age at 71, with 43% women.

In 2024, Dr. Turner wrote 593 Medicare Part D claims for 134 patients. 89% of them were for generic drugs. CMS names the drug for 332 of them, across 18 drugs with 11 or more claims each, at $49,107 in total drug cost. In 2023, CMS named 272 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Turner for performance year 2024, reported as part of a group. Dr. Turner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Turner as offering telehealth.

Dmand AI links 45 papers to Dr. Turner, published from 2010 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Heart Failure, Diuretics and Renal Insufficiency, Chronic. Dr. Turner has published most often in Circ Heart Fail. Dr. Turner's most frequent co-authors are Jeffrey Moore Testani, MD, Francis P. Wilson, MD and Christopher Dionisio Maulion, MD.

Dmand AI links Dr. Turner to 2 clinical trials. 1 is still active or recruiting. Conditions studied include dopamine beta hydroxylase deficiency, Hypertension and Pure Autonomic Failure. Open Payments lists research payments to Dr. Turner that name 2 trials.

CMS Open Payments shows 19 general payments to Dr. Turner from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 50% of the total. Fresenius USA Marketing, Inc. paid the most, $2,637. It also lists 10 research payments totaling $3,032 from 2019 to 2025, naming 2 clinical trials.

Dr. Turner graduated from New York Medical College in 2005.